IRBESARTAN REDUCES LIVER DAMAGE INDUCED BY LIPOPOLYSACCHARIDE VIA INHIBITION OF TOTAL OXIDANT STATUS, INTERLEUKIN-1B AND CASPASE-3 LEVELS.
| Autor: | NURLU TEMEL, Esra1 dresratemel@gmail.com, AĞIRCA TAŞAN, Şerife2, İLHAN, İlter3 |
|---|---|
| Zdroj: | Medical Journal of Suleyman Demirel University. Sep2023, Vol. 30 Issue 3, p474-483. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|